TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in TScan Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 81
- +16 vs. Q1 2024
- Shares held
- 41.5M
- +7.20M (+21.0%) vs. Q1 2024
- Total value
- $242.6M
- −$29.6M (−10.9%) vs. Q1 2024
- New holders
- 32
- 19 more added
- Sold out
- 16
- 14 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $35.1M |
| Q1 2026 | 60 | $32.8M |
| Q4 2025 | 61 | $30.7M |
| Q3 2025 | 73 | $62.9M |
| Q2 2025 | 81 | $51.8M |
| Q1 2025 | 92 | $55.4M |
| Q4 2024 | 89 | $126.2M |
| Q3 2024 | 89 | $208.3M |
| Q2 2024 | 81 | $242.6M |
| Q1 2024 | 66 | $272.3M |
| Q4 2023 | 54 | $186.1M |
| Q3 2023 | 32 | $73.2M |
| Q2 2023 | 28 | $69.9M |
| Q1 2023 | 28 | $20.3M |
| Q4 2022 | 28 | $14.8M |
| Q3 2022 | 26 | $29.0M |
| Q2 2022 | 24 | $30.4M |
| Q1 2022 | 25 | $26.3M |
| Q4 2021 | 29 | $44.4M |
| Q3 2021 | 27 | $83.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding TScan Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 5,224,600 | $30.6M | 11.03% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 5,000,000 | $29.3M | 0.90% | 00.0% | Unchanged |
| BlackRock Inc. | 4,462,352 | $26.1M | 0.00% | +2,763,139+162.6% | Added |
| Adage Capital Partners GP, L.L.C. | 4,400,000 | $25.7M | 0.05% | +500,000+12.8% | Added |
| BVF Inc | 2,989,474 | $17.5M | 0.49% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,784,792 | $16.3M | 0.21% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,133,613 | $12.5M | 0.00% | +325,461+18.0% | Added |
| Propel Bio Management, LLC | 2,087,139 | $12.2M | 7.92% | 00.0% | Unchanged |
| Deer Management Co. LLC | 1,245,504 | $7.29M | 1.50% | 00.0% | Unchanged |
| Alphabet Inc. | 1,077,080 | $6.30M | 0.32% | 00.0% | Unchanged |
| Simplify Asset Management Inc. | 1,046,916 | $6.12M | 0.54% | 00.0% | Unchanged |
| Great Point Partners LLC | 940,831 | $5.50M | 1.05% | +940,831 | New |
| Geode Capital Management, LLC | 900,499 | $5.27M | 0.00% | +486,720+117.6% | Added |
| StemPoint Capital LP | 845,069 | $4.94M | 1.45% | +845,069 | New |
| LMR Partners LLP | 665,529 | $3.89M | 0.08% | +665,529 | New |
| DC Funds, LP | 630,000 | $3.69M | 61.20% | 00.0% | Unchanged |
| State Street Corp | 608,085 | $3.56M | 0.00% | +473,085+350.4% | Added |
| Invesco Ltd. | 499,874 | $2.92M | 0.00% | +11,459+2.3% | Added |
| Paradigm Biocapital Advisors LP | 353,886 | $2.07M | 0.08% | +353,886 | New |
| Marshall Wace, LLP | 307,487 | $1.80M | 0.00% | +116,316+60.8% | Added |
| Standard Life Aberdeen plc | 292,144 | $1.71M | 0.00% | +92,144+46.1% | Added |
| Morgan Stanley | 241,672 | $1.41M | 0.00% | +17,778+7.9% | Added |
| Tocqueville Asset Management L.P. | 209,830 | $1.23M | 0.02% | −2,370−1.1% | Reduced |
| Woodline Partners LP | 163,492 | $956.4K | 0.01% | +163,492 | New |
| Citadel Advisors LLC | 157,963 | $924.1K | 0.00% | +146,531+1,281.8% | Added |
| Alpine Global Management, LLC | 137,490 | $804.3K | 0.14% | +137,490 | New |
| Bank of Montreal | 120,454 | $749.2K | 0.00% | +120,454 | New |
| Bank of New York Mellon Corp | 116,658 | $682.4K | 0.00% | +116,658 | New |
| Charles Schwab Investment Management Inc | 112,941 | $660.7K | 0.00% | +90,837+411.0% | Added |
| Walleye Capital LLC | 107,665 | $629.8K | 0.01% | +55,187+105.2% | Added |
| Jane Street Group, LLC | 99,036 | $579.4K | 0.00% | −54,097−35.3% | Reduced |
| Northern Trust Corp | 97,512 | $570.4K | 0.00% | +20,552+26.7% | Added |
| Stifel Financial Corp | 95,400 | $558.1K | 0.00% | −6,000−5.9% | Reduced |
| Troluce Capital Advisors LLC | 92,832 | $543.1K | 0.11% | +92,832 | New |
| NewEdge Wealth, LLC | 91,463 | $535.1K | 0.01% | 00.0% | Unchanged |
| Wellington Management Group LLP | 90,941 | $532.0K | 0.00% | +90,941 | New |
| Renaissance Technologies LLC | 80,000 | $468.0K | 0.00% | +33,000+70.2% | Added |
| Qube Research & Technologies Ltd | 78,385 | $458.6K | 0.00% | −65,151−45.4% | Reduced |
| Brown Brothers Harriman & Co | 76,024 | $444.7K | 0.00% | +76,024 | New |
| Nuveen Asset Management, LLC | 69,962 | $409.3K | 0.00% | +69,962 | New |
| Laurion Capital Management LP | 60,400 | $353.3K | 0.01% | −302,084−83.3% | Reduced |
| American Century Companies Inc | 47,481 | $277.8K | 0.00% | +15,596+48.9% | Added |
| Rhumbline Advisers | 46,867 | $274.2K | 0.00% | +46,867 | New |
| Bank of America Corp | 43,782 | $256.1K | 0.00% | +13,603+45.1% | Added |
| Bridgeway Capital Management, LLC | 38,300 | $224.1K | 0.01% | −25,000−39.5% | Reduced |
| DC Investments Management, LLC | 35,563 | $208.0K | 0.18% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 35,268 | $206.3K | 0.00% | −224,880−86.4% | Reduced |
| Millennium Management LLC | 27,889 | $163.2K | 0.00% | −364,226−92.9% | Reduced |
| Cornercap Investment Counsel Inc | 22,940 | $134.2K | 0.02% | +22,940 | New |
| EntryPoint Capital, LLC | 21,899 | $128.1K | 0.06% | +21,899 | New |
| Pale Fire Capital SE | 21,573 | $126.2K | 0.01% | 00.0% | Unchanged |
| Letko, Brosseau & Associates Inc | 20,700 | $121.1K | 0.00% | 00.0% | Unchanged |
| Corebridge Financial, Inc. | 20,658 | $121.1K | 0.00% | +20,658 | New |
| Deutsche Bank AG | 20,638 | $120.7K | 0.00% | +20,638 | New |
| New York State Common Retirement Fund | 20,093 | $117.5K | 0.00% | +20,093 | New |
| Squarepoint Ops LLC | 19,290 | $112.8K | 0.00% | +19,290 | New |
| Man Group plc | 18,651 | $109.1K | 0.00% | −58,688−75.9% | Reduced |
| JPMorgan Chase & Co | 16,364 | $95.7K | 0.00% | −50,649−75.6% | Reduced |
| Manufacturers Life Insurance Company, The | 15,383 | $90.0K | 0.00% | +15,383 | New |
| Wells Fargo & Company | 13,886 | $81.2K | 0.00% | +13,580+4,437.9% | Added |
| Voya Investment Management LLC | 13,603 | $79.6K | 0.00% | +13,603 | New |
| Marathon Trading Investment Management LLC | 13,600 | $79.6K | 0.02% | −37,400−73.3% | Reduced |
| Barclays PLC | 13,164 | $77.0K | 0.00% | +13,164 | New |
| UBS Group AG | 12,645 | $74.0K | 0.00% | +10,744+565.2% | Added |
| Advisor Group Holdings, Inc. | 12,245 | $71.6K | 0.00% | +12,245 | New |
| Dimensional Fund Advisors LP | 11,882 | $70.5K | 0.00% | +11,882 | New |
| Privium Fund Management (UK) Ltd | 12,103 | $69.3K | 0.03% | −3,722−23.5% | Reduced |
| Jump Financial, LLC | 10,792 | $63.1K | 0.00% | +501+4.9% | Added |
| MetLife Investment Management | 10,199 | $59.7K | 0.00% | +10,199 | New |
| Waldron Private Wealth LLC | 10,000 | $58.5K | 0.00% | 00.0% | Unchanged |
| Aries Wealth Management | 10,000 | $58.5K | 0.02% | 00.0% | Unchanged |
| Citigroup Inc | 8,446 | $49.4K | 0.00% | −108,475−92.8% | Reduced |
| Tower Research Capital LLC (TRC) | 4,224 | $24.7K | 0.00% | +4,224 | New |
| Legal & General Group Plc | 3,937 | $23.0K | 0.00% | +3,937 | New |
| Ameritas Investment Partners, Inc. | 3,762 | $22.0K | 0.00% | +3,762 | New |
| Royal Bank of Canada | 3,611 | $21.0K | 0.00% | +3,611 | New |
| California State Teachers Retirement System | 2,782 | $16.3K | 0.00% | +2,782 | New |
| Amalgamated Bank | 1,329 | $8.00K | 0.00% | +1,329 | New |
| Atlas Capital Advisors LLC | 18 | $105 | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 176 | $0 | 0.00% | −2,375−93.1% | Reduced |
| Price T Rowe Associates Inc | 12,301 | $0 | 0.00% | +12,301 | New |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −297,902−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −44,308−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −41,942−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −37,747−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −35,661−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −34,789−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −34,578−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −24,446−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −19,736−100.0% | Sold out |
| Cannon Global Investment Management, LLC | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −14,200−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −12,200−100.0% | Sold out |
| CTC Alternative Strategies, Ltd. | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −10,061−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −1,618−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |